Single-session Combined Therapy with Chemoembolization and Radiofrequency Ablation in Hepatocellular Carcinoma Less than or Equal to 5 cm: A Preliminary Study

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 12, 2009, Pages 1570-1577

  Kang, Sung Gwon ^a   Yoon, Chang Jin ^a   Jeong, Sook Hyang ^a   Kim, Jin Wook ^a   Lee, Sang Hyub ^a   Lee, Kyung Ho ^a   Kim, Young Hoon ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADRIAMYCIN RDF; DOXORUBICIN; IODINATED POPPYSEED OIL; LIPIODOL ULTRA FLUID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CATHETER; CAUSE OF DEATH; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ECHOGRAPHY; ELECTRODE; EMULSION; ESOPHAGUS VARICES BLEEDING; FEMALE; FLUOROSCOPY; FOLLOW UP; HEPATIC ARTERY; HUMAN; INFARCTION; INTERVENTIONAL RADIOLOGY; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER FAILURE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATIENT SAFETY; PERITONITIS; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TREATMENT OUTCOME; ULTRASOUND;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; GELATIN SPONGE, ABSORBABLE; HUMANS; IODIZED OIL; KAPLAN-MEIERS ESTIMATE; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PILOT PROJECTS; RADIOGRAPHY, INTERVENTIONAL; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 70450233496     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2009.09.003     Document Type: Article

References (16)

1. Llovet J.M., and Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 48 Suppl 1 (2008) S20-S37
2. Brown D.B., Gould J.E., Gervais D.A., et al. Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol 18 (2007) 1469-1478
3. Takaki H., Yamakado K., Nakatsuka A., et al. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression. J Vasc Interv Radiol 18 (2007) 856-861
4. Yamakado K., Nakatsuka A., Akeboshi M., Shiraki K., Nakano T., and Takeda K. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: short-term recurrences and survival. Oncol Rep 11 (2004) 105-109
5. Yamakado K., Nakatsuka A., Ohmori S., et al. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol 13 (2002) 1225-1232
6. Yamakado K., Nakatsuka A., Takaki H., et al. Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. Radiology 247 (2008) 260-266
7. Yuen M.F., and Lai C.L. Serological markers of liver cancer. Best Pract Res Clin Gastroenterol 19 (2005) 91-99
8. Veltri A., Moretto P., Doriguzzi A., Pagano E., Carrara G., and Gandini G. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol 16 (2006) 661-669
9. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35 (2001) 421-430
10. Sacks D., McClenny T.E., Cardella J.F., and Lewis C.A. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14 (2003) S199-S202
11. Kitamoto M., Imagawa M., Yamada H., et al. Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization. AJR Am J Roentgenol 181 (2003) 997-1003
12. Higgins M.C., and Soulen M.C. Multimodality approaches for control of hepatocellular carcinoma. Tech Vasc Interv Radiol 10 (2007) 64-66
13. Helmberger T., Dogan S., Straub G., et al. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma. Digestion 75 (2007) 104-112
14. Akahane M., Koga H., Kato N., et al. Complications of percutaneous radiofrequency ablation for hepatocellular carcinoma: imaging spectrum and management. Radiographics 25 Suppl 1 (2005) S57-S68
15. Kim T.K., Choi B.I., Han J.K., Chung J.W., Park J.H., and Han M.C. Nontumorous arterioportal shunt mimicking hypervascular tumor in cirrhotic liver: two-phase spiral CT findings. Radiology 208 (1998) 597-603
16. Rhim H., Lee M.H., Kim Y.S., Choi D., Lee W.J., and Lim H.K. Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas. AJR Am J Roentgenol 190 (2008) 1324-1330